Identification of MFI2-AS1, a Novel Pivotal lncRNA for Prognosis of Stage III/IV Colorectal Cancer
- PMID: 31960204
- DOI: 10.1007/s10620-020-06064-1
Identification of MFI2-AS1, a Novel Pivotal lncRNA for Prognosis of Stage III/IV Colorectal Cancer
Abstract
Background: Long noncoding RNAs (lncRNAs) have been shown to play pivotal role in pathogenesis and prognosis of cancers. Identification of novel clinical biomarkers in advanced stage colorectal cancer (CRC) is warranted.
Aims: To identify potential lncRNAs associated with progression of stage III/IV CRC and illuminate regulatory mechanisms.
Methods: Differentially expressed lncRNAs, mRNAs and miRNAs (DElncRNAs, DEmRNAs, and DEmiRNAs) were extracted between stage III/IV CRC and normal tissues. We used DEGs to construct a ceRNA network and analyzed correlations between key lncRNAs and overall survivals (OS) of stage III/IV CRC patients. Weighted gene co-expression network analysis (WGCNA) was applied to a pivotal lncRNA. We conducted functional enrichment analysis on target genes and constructed lncRNA-TF-mRNA network by overlapping mRNAs co-expressed with the key lncRNA and target genes of transcriptional factors (TFs).
Results: A total of 26 DElncRNAs, 398 DEmiRNAs, 2155 DEmRNAs were identified. A ceRNA network was constructed with 16 lncRNAs, 20 miRNAs, and 59 mRNAs, in which MFI2-AS1 exhibited promising diagnostic efficiency. (AUC was 0.938.) MFI2-AS1 was negatively correlated to OS of stage III/IV CRC patients (P value < 0.05). KEGG analysis showed potential mRNA targets of MFI2-AS1 mainly involved in cell cycle and cytokine-cytokine receptor interaction. We identified 17 potential TFs of MFI2-AS1 and built a lncRNA-TF-mRNA network.
Conclusion: Our study provides novel insights into lncRNAs associated regulatory networks and reveals a promising lncRNA biomarker, MFI2-AS1, as an independent prognostic indicator and potential therapeutic target for CRC.
Keywords: CeRNA network; Co-expression analysis; Colorectal cancer; LncRNAs; Prognosis.
Similar articles
-
A Competing Endogenous RNA Network Reveals Novel lncRNA, miRNA and mRNA Biomarkers With Diagnostic and Prognostic Value for Early Breast Cancer.Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820983293. doi: 10.1177/1533033820983293. Technol Cancer Res Treat. 2020. PMID: 33371806 Free PMC article.
-
LncRNA-Associated ceRNA Network Reveals Novel Potential Biomarkers of Laryngeal Squamous Cell Carcinoma.Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820985787. doi: 10.1177/1533033820985787. Technol Cancer Res Treat. 2020. PMID: 33371795 Free PMC article.
-
Reconstruction and Analysis of the Differentially Expressed IncRNA-miRNA-mRNA Network Based on Competitive Endogenous RNA in Hepatocellular Carcinoma.Crit Rev Eukaryot Gene Expr. 2019;29(6):539-549. doi: 10.1615/CritRevEukaryotGeneExpr.2019028740. Crit Rev Eukaryot Gene Expr. 2019. PMID: 32422009 Review.
-
Long Noncoding RNA (lncRNA)-Mediated Competing Endogenous RNA Networks Provide Novel Potential Biomarkers and Therapeutic Targets for Colorectal Cancer.Int J Mol Sci. 2019 Nov 16;20(22):5758. doi: 10.3390/ijms20225758. Int J Mol Sci. 2019. PMID: 31744051 Free PMC article. Review.
-
Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.J Transl Med. 2018 Sep 27;16(1):264. doi: 10.1186/s12967-018-1640-2. J Transl Med. 2018. PMID: 30261893 Free PMC article.
Cited by
-
Exploring the Key Signaling Pathways and ncRNAs in Colorectal Cancer.Int J Mol Sci. 2024 Apr 21;25(8):4548. doi: 10.3390/ijms25084548. Int J Mol Sci. 2024. PMID: 38674135 Free PMC article. Review.
-
Somatic Copy Number Alterations in Colorectal Cancer Lead to a Differentially Expressed ceRNA Network (ceRNet).Curr Issues Mol Biol. 2023 Nov 28;45(12):9549-9565. doi: 10.3390/cimb45120597. Curr Issues Mol Biol. 2023. PMID: 38132443 Free PMC article.
-
Role of Non-Coding RNAs in TGF-β Signalling in Glioma.Brain Sci. 2023 Sep 27;13(10):1376. doi: 10.3390/brainsci13101376. Brain Sci. 2023. PMID: 37891744 Free PMC article. Review.
-
Establishment and validation of a redox-related long non-coding RNAs prognostic signature in head and neck squamous cell carcinoma.Sci Rep. 2022 Dec 21;12(1):22040. doi: 10.1038/s41598-022-26490-7. Sci Rep. 2022. PMID: 36543836 Free PMC article.
-
lncRNA2919 Suppresses Rabbit Dermal Papilla Cell Proliferation via trans-Regulatory Actions.Cells. 2022 Aug 6;11(15):2443. doi: 10.3390/cells11152443. Cells. 2022. PMID: 35954286 Free PMC article.
References
-
- Melina A, Sierra Mónica S, Mathieu L, et al. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66:683–691. - DOI
-
- Miller Kimberly D, Siegel Rebecca L, Chieh LC, et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016;66:271–289. - DOI
-
- Gomes AQ, Nolasco S, Soares H. Non-coding RNAs: multi-tasking molecules in the cell. Int J Mol Sci. 2013;14:16010–16039. - DOI
-
- Ye LC, Zhu X, Qiu JJ, Xu J, Wei Y. Involvement of long non-coding RNA in colorectal cancer: from benchtop to bedside (review). Oncol Lett. 2015;9:1039–1045. - DOI
-
- Li J, Wang X, Tang J, et al. HULC and Linc00152 act as novel biomarkers in predicting diagnosis of hepatocellular carcinoma. Cell Physiol Biochem. 2015;37:687–696. - DOI
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous